Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2026-01-11 @ 8:50 PM
Study NCT ID:
NCT01271920
Status:
COMPLETED
Last Update Posted:
2020-12-08
First Post:
2010-11-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced HER2-positive Breast Cancer | View |